Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−70.22 USD
−75.34 M USD
0.00 USD
423.41 K
About Portage Biotech Inc.
Sector
Industry
CEO
Ian B. Walters
Website
Headquarters
Road Town
Founded
1973
FIGI
BBG000L8TTY6
Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PRTG is 4.62 USD — it has increased by 2.21% in the past 24 hours. Watch Portage Biotech Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Portage Biotech Inc. stocks are traded under the ticker PRTG.
PRTG stock has risen by 11.59% compared to the previous week, the month change is a −22.35% fall, over the last year Portage Biotech Inc. has showed a −83.96% decrease.
PRTG reached its all-time high on Dec 23, 1999 with the price of 16,375.00 USD, and its all-time low was 0.20 USD and was reached on Nov 20, 2018. View more price dynamics on PRTG chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PRTG stock is 16.52% volatile and has beta coefficient of 2.95. Track Portage Biotech Inc. stock price on the chart and check out the list of the most volatile stocks — is Portage Biotech Inc. there?
Today Portage Biotech Inc. has the market capitalization of 3.08 M, it has increased by 10.51% over the last week.
Yes, you can track Portage Biotech Inc. financials in yearly and quarterly reports right on TradingView.
Portage Biotech Inc. is going to release the next earnings report on Nov 26, 2024. Keep track of upcoming events with our Earnings Calendar.
PRTG net income for the last quarter is −1.66 M USD, while the quarter before that showed −24.89 M USD of net income which accounts for 93.35% change. Track more Portage Biotech Inc. financial stats to get the full picture.
No, PRTG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 7.00 employees. See our rating of the largest employees — is Portage Biotech Inc. on this list?
Like other stocks, PRTG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Portage Biotech Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Portage Biotech Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Portage Biotech Inc. stock shows the sell signal. See more of Portage Biotech Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.